Digital Health App Tracks Pain Progress With Neurostimulation Therapy
Patients will be able to share information collected in the app with health care providers to provide a comprehensive assessment of the SCS or DRG therapy.
Medical Devices
Latest Health Technology at CES 2021
MPR highlights health innovations from the 2021 Consumer Electronics Show (CES).
FDA Authorizes Digital Therapeutic for Sleep Disturbance in PTSD
NightWare is a smartwatch application that uses the Apple Watch and Apple iPhone platform.
FDA Approves DBS Neurostimulation System With Brain Signal Tracking
The FDA has approved the Percept™ PC Deep Brain Stimulation (DBS) system (Medtronic) with BrainSense™ technology for neurological disorders.
Infinity DBS System Gains Expanded Approval for Parkinson Disease Management
The FDA has approved an expanded indication for the Infinity™ Deep Brain Stimulation (DBS) system (Abbott) to include targeting the internal globus pallidus, which may lead to symptom improvement in patients with Parkinson disease.
Wearable Device Data May Help Predict Flu-Like Illness Patterns
Fitbit data significantly improved prediction of influenza-like illness in top five states with most users
FDA Approves Unique SCS System for Chronic Pain
The Food and Drug Administration (FDA) has approved the Senza Omnia Spinal Cord Stimulation (SCS) System (Nevro) for the treatment of chronic intractable pain of the trunk and/or limbs. The Omnia SCS system is the first to deliver Nevro’s proprietary HF10 therapy (continuous stimulation at 10,000 Hz) as well as all other available SCS frequences…
MPR Weekly Dose Podcast: Episode 7
This week we talk about the new Invokana approval; The ranitidine recalls that led CVS to suspend all sales; The 11 serious cybersecurity vulnerabilities identified by the FDA that could affect medical devices and hospital networks; Entresto’s expanded indication; and the investigative COPD treatment that was rejected.
FDA: Cybersecurity Vulnerabilities Identified With Certain Medical Devices, Hospital Networks
The Food and Drug Administration (FDA) has issued an alert regarding a set of cybersecurity vulnerabilities that may potentially introduce risks for certain medical devices and hospital networks. Security researchers have determined 11 vulnerabilities, referred to as “URGENT/11”, that may potentially allow an unauthorized user to take control of a facilities’ medical network leading to…
FDA Clears Smartwatch, Patch for Cuffless BP Monitoring
The FDA has granted 510K clearance to BioBeat’s wearable watch and patch for continuous monitoring of blood pressure, heart rate and oxygenation.
